Manager News

Summit Partners fund closes at $8.35bn after four months

Summit Partners closed its latest flagship U.S. growth equity fund at its hard cap of $8.35 billion, officials confirmed earlier…

Read More »

Music Benefactors and other forces for change in music industry finance

Music Benefactors, an SEC-registered investment platform that assists recording artists in raising capital for their projects, is in large part…

Read More »

Blackstone Life Sciences adds two managing directors

Dr. Monika Vnuk and Matt Lane have joined Blackstone Life Sciences (BXLS) as managing directors based in Cambridge, Massachusetts. Dr.…

Read More »

FocusPoint Europe opens London office to boost access to U.S. private markets

FocusPoint Private Capital Group (FPCG) established its FocusPoint Europe (FPE) affiliate to help European institutional investors access U.S. private market…

Read More »

Blacktsone validates music rights as alts assets with $1bn partnership

If there were any doubts left about the value of music rights as an alternative investment asset class, the $1…

Read More »

Apollo-backed HarbourView Equity Partners launches $1bn entertainment fund

HarbourView Equity Partners, a global alternative asset manager focused on the media and entertainment space, has launched a $1 billion…

Read More »

KKR taps successors to Kravis and Roberts

KKR appointed Joe Bae and Scott Nuttall co-chief executive officers as Co-Founders Henry Kravis and George Roberts remain actively involved…

Read More »

VC FoFs Northgate closes ninth fund

Bay Area venture capital investment firm Northgate closed last month its latest fund as co-founders Brent Jones and Tommy Vardell…

Read More »

European life sciences player HealthCap announces new hire, promotions

European life sciences venture capital firm HealthCap appointed Dr. Mårten Steen as co-managing partner, taking a seat alongside Founding Partner…

Read More »

UBS kicks MPM Capital oncology impact fund into record territory

MPM Capital expected to raise $650 million for its second Oncology Impact Fund (OIF 2), which would have been more…

Read More »
Back to top button